Oncolytics Biotech (ONCY) Tops Q4 EPS by 10c
Oncolytics Biotech (NASDAQ: ONCY) reported Q4 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
Oncolytics Biotech (NASDAQ: ONCY) reported Q4 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.